Publications by authors named "Hiroyuki Hata"

Claim this Profile
A
A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee.
Shin-Ichi Fuchida, Mizuki Ogura, Tadao Ishida, Hiroyuki Hata, Hiroshi Handa

Int J Hematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab, lenalidomide and dexamethasone in newly diagnosed systemic light chain amyloidosis patients associated with multiple myeloma.
Yawara Kawano, Hiroyuki Hata, Seiji Takashio, Kenichi Tsujita, Mitsuharu Ueda

Br J Haematol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of a novel enhancer in the HTLV-1 proviral genome.
Misaki Matsuo, Takaharu Ueno, Kazuaki Monde, Kenji Sugata, Benjy Jek Yang Tan, Hiroyuki Hata

Nat Commun· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel PDK1 inhibitor, JX06, inhibits glycolysis and induces apoptosis in multiple myeloma cells.
Yawara Kawano, Takayuki Sasano, Yuichiro Arima, Saki Kushima, Kenichi Tsujita, Hiroyuki Hata

Biochem Biophys Res Commun· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical potential of dual-energy cardiac CT in cardiac amyloidosis.
Seitaro Oda, Takeshi Nakaura, Daisuke Utsunomiya, Kyoko Hirakawa, Seiji Takashio, Hiroyuki Hata

Amyloid· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AL amyloidosis diagnosed using anti-IGLL5 antibody: a case report.
Takayuki Hiroi, Toshiki Mushino, Ken Tanaka, Yoshiaki Furuya, Yoshikazu Hori, Hiroyuki Hata

Amyloid· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Spontaneous remission of acquired factor XIII inhibitor concurrent to development of IgA-λ type multiple myeloma].
Shikiko Ueno, Junko Nozaki, Shinichi Kusano, Yawara Kawano, Yoshitaka Kikukawa, Hiroyuki Hata

Rinsho Ketsueki· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells.
Nao Nishimura, Mohamed O Radwan, Masayuki Amano, Shinya Endo, Eri Fujii, Hiroyuki Hata

Cancer Sci· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Nature of the HTLV-1 Provirus in Naturally Infected Individuals Analyzed by the Viral DNA-Capture-Seq Approach.
Hiroo Katsuya, Saiful Islam, Benjy Jek Yang Tan, Jumpei Ito, Paola Miyazato, Hiroyuki Hata

Cell Rep· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Q Gene Mycobacteria: A novel and easy nucleic acid chromatography method for mycobacterial species identification.
Kinuyo Chikamatsu, Akio Aono, Akiko Kawai, Hiroyuki Hata, Tomotada Iwamoto

J Microbiol Methods· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-1. Multiple myeloma (MM).
Shinsuke Iida, Tadao Ishida, Hirokazu Murakami, Shuji Ozaki, Masahiro Abe, Hiroyuki Hata

Int J Hematol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma.
Tetsuhiro Kasamatsu, Shuji Ozaki, Takayuki Saitoh, Jun Konishi, Kazutaka Sunami, Hiroyuki Hata

Hematol Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MUC1/KL-6 expression confers an aggressive phenotype upon myeloma cells.
Shinya Endo, Nao Nishimura, Yawara Kawano, Niina Ueno, Shikiko Ueno, Hiroyuki Hata

Biochem Biophys Res Commun· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pancytopenia and Myelodysplastic Changes in Aceruloplasminemia: A Case with a Novel Pathogenic Variant in the Ceruloplasmin Gene.
Ayako Yamamura, Yoshitaka Kikukawa, Kenji Tokunaga, Eiko Miyagawa, Shinya Endo, Hiroyuki Hata

Intern Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late iodine enhancement and myocardial extracellular volume quantification in cardiac amyloidosis by using dual-energy cardiac computed tomography performed on a dual-layer spectral detector scanner.
Seitaro Oda, Takeshi Nakaura, Daisuke Utsunomiya, Kyoko Hirakawa, Seiji Takashio, Hiroyuki Hata

Amyloid· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bufalin induces DNA damage response under hypoxic condition in myeloma cells.
Eri Fujii, Yuki Inada, Misaki Kakoki, Nao Nishimura, Shinya Endo, Hiroyuki Hata

Oncol Lett· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan.
Chihiro Shimazaki, Hiroyuki Hata, Sinsuke Iida, Mitsuharu Ueda, Nagaaki Katoh

Intern Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of PyroMark Q24 pyrosequencing as a method for the identification of mycobacteria.
Kinuyo Chikamatsu, Akio Aono, Hiroyuki Hata, Yuriko Igarashi, Akiko Takaki

Diagn Microbiol Infect Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Analysis of deposited peptides in amyloid lesions of AL amyloidosis by mass spectrometry].
Toshiya Sugimoto, Masayoshi Tasaki, Taro Yamashita, Mitsuharu Ueda, Yukio Ando, Hiroyuki Hata

Rinsho Ketsueki· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and Assessment of Cardiac Amyloidosis by Myocardial Strain Analysis of Cardiac Magnetic Resonance Imaging.
Seitaro Oda, Daisuke Utsunomiya, Takeshi Nakaura, Hideaki Yuki, Masafumi Kidoh, Hiroyuki Hata

Circ J· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A xenograft model reveals that PU.1 functions as a tumor suppressor for multiple myeloma in vivo.
Nao Nishimura, Shinya Endo, Shikiko Ueno, Nina Ueno, Hiro Tatetsu, Hiroyuki Hata

Biochem Biophys Res Commun· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Treatment of Amyloid Light-chain Amyloidosis in a Charcot-Marie-Tooth Disease Patient with Lenalidomide, Cyclophosphamide, and Dexamethasone.
Yoshitaka Kikukawa, Hiroyuki Hata, Mitsuharu Ueda, Taro Yamashita, Singo Nasu

Intern Med· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
Shiho Fujiwara, Hiromi Mochinaga, Hirotomo Nakata, Koichi Ohshima, Masanori Matsumoto, Hiroyuki Hata

Int J Hematol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phylogenetics of family Enterobacteriaceae and proposal to reclassify Escherichia hermannii and Salmonella subterranea as Atlantibacter hermannii and Atlantibacter subterranea gen. nov., comb. nov.
Hiroyuki Hata, Tatsuya Natori, Takuya Mizuno, Izumi Kanazawa, Ibrahim Eldesouky

Microbiol Immunol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced frequency treatment with bortezomib plus dexamethasone for elderly patients with relapsed and/or refractory multiple myeloma: a phase 2 study of the Japanese Myeloma Study Group (JMSG-0902).
Shuji Ozaki, Hiroyuki Hata, Masahiro Abe, Takayuki Saitoh, Ichiro Hanamura

Ann Hematol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis